Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Papua New Guinea records 351 new COVID-19 cases

Published 24/03/2021, 08:32 pm
Updated 24/03/2021, 08:36 pm

SYDNEY, March 24 (Reuters) - Papua New Guinea recorded 351 new coronavirus cases and two deaths on Tuesday, as 8,000 vaccines arrived from Australia to assist health workers in overburdened hospitals.

The Pacific island nation has seen cases jump by 1,000 in six days, COVID-19 National Pandemic Response controller David Manning said in a statement on Wednesday.

Officials have tightened internal border controls and enforced mask-wearing in public as the country confronts the steep rise in infections. has recorded 4,109 cases and 39 deaths, most since the start of the month.

Half of the new cases recorded on Tuesday were asymptomatic, raising concerns the coronavirus was circulating widely in the community. Western province, which is closest to Australia, accounted for about 50% of the daily rise.

Charities and health workers said last week that the pandemic had hit PNG's fragile health system "like a tornado", with services shutting as staff fall ill. 60,680 tests for COVID-19 have been conducted in a population of 9 million, nearly all of whom live in rural areas, many in isolated mountainous villages.

The emergency vaccine doses from the Australian Government are the first to arrive in the country and will be given to health workers.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.